90562-37-1

Upstream product

• 20939-77-9 2-acetamidobenzyl alcohol 
• 75-44-5 phosgene 
• 67-66-3 chloroform 
• 108-88-3 toluene 
• 133390-35-9 2-[Benzyl-(2-nitro-benzyl)-amino]-1-phenyl-ethanol 
• 133406-89-0 2-(o-aminobenzyl)-4-phenyl-1,2,3,4-tetrahydroisoquinoline 
• 5344-90-1 2-Aminobenzyl alcohol 
• 133390-34-8 2-[Benzyl-(2-nitro-benzyl)-amino]-1-phenyl-ethanone 
• 95982-61-9 o-nitro-N-benzyl(benzylamine) 
• 541-41-3 chloroformic acid ethyl ester 
• 133390-28-0 2-(o-acetylaminobenzyl)-4-phenyl-1,2,3,4-tetrahydroisoquinoline 
• 552-89-6 2-nitro-benzaldehyde 
• 133390-25-7 2-[(2-Amino-benzyl)-benzyl-amino]-1-phenyl-ethanol 
• 911291-94-6 benzyl-(2-nitro-benzyliden)-amine 

Downstream Products

• 1184787-69-6 N-[2-(azidomethyl)phenyl]acetamide 
• 106747-41-5 N-[2-[(1H-benzimidazol-2-ylthio)methyl]phenyl]acetamide 

Relevant academic research and scientific papers

Synthesis of 1-acyl-3,4-dihydroquinazoline-2(1H)-thiones by cyclization of N-[2-(isothiocyanatomethyl)phenyl] amides generated in situ from N-[2-(azidomethyl)phenyl] amides

An efficient method for the preparation of 1-acyl-3,4-dihydroquinazoline- 2(1H)-thiones 5 has been developed. The reaction of N-[2-(azidomethyl)phenyl] amides 3, easily prepared by a three-step sequence starting with (2-aminophenyl)methanols, with Ph

2-?(1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines

This invention relates to 2-?(1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines that are useful in the treatment and prevention of ulcers.

CYCLIZATION OF N-(2-AMINOBENZYL) BENZYLAMINO-1-PHENYL-1-ETHANOLS AND DEBENZYLATION OF THE RESULTING TETRAHYDROISOQUINOLINE DERIVATIVES

Debenzylation reactions of 2-(o-aminobenzyl)-4-phenyl-1,2,3,4-tetrahydroisoquinolines (3a, b) and their N-acetyl derivatives (4a, b), obtained by the cyclization of N-(2-aminobenzyl)benzylamino-1-phenyl-1-ethanols (1), were studied.

Imidazopyridine compounds and processes for preparation thereof

The invention relates to an imidazopyridine compound of the formula: STR1 wherein R1 is lower alkynyl, lower alkynyloxy(lower)alkyl or N,N-di(lower)alkylamino(lower)alkynyl, R2 is lower alkyl, R3 is mono (or di or tri)-phenyl(lower)alkyl substituted by one or more substituent(s) selected from cyano, carbamoyl, mono (or di or tri(phenyl(lower)alkylamino, acylamino, carboxy, esterified carboxy, hydroxy, hydroxy(lower)alkyl, acyloxy(lower)alkyl, acyloxy, mono (or di or tri)phenyl(lower)alkoxy, lower alkoxy(lower)alkoxy, tetrahydropyranyloxy, and acylamino(lower)alkyl or mono (or di or tri) phenyl(lower)alkyl substituted by lower alkyl and one additional substituent selected from hydroxy(lower)alkyl, amino, N-lower alkyl-N-acylamino, mono (or di or tri)phenyl(lower)alkylamino, acylamino and lower alkylamino, and R4 is hydrogen or lower alkyl, and a pharmaceutically acceptable salt thereof, useful in the treatment of ulcers.